Correlation Between Moleculin Biotech and Mediwound

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Mediwound at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Mediwound into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Mediwound, you can compare the effects of market volatilities on Moleculin Biotech and Mediwound and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Mediwound. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Mediwound.

Diversification Opportunities for Moleculin Biotech and Mediwound

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Moleculin and Mediwound is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Mediwound in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mediwound and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Mediwound. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mediwound has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Mediwound go up and down completely randomly.

Pair Corralation between Moleculin Biotech and Mediwound

Given the investment horizon of 90 days Moleculin Biotech is expected to generate 2.48 times more return on investment than Mediwound. However, Moleculin Biotech is 2.48 times more volatile than Mediwound. It trades about 0.07 of its potential returns per unit of risk. Mediwound is currently generating about -0.05 per unit of risk. If you would invest  254.00  in Moleculin Biotech on August 31, 2024 and sell it today you would earn a total of  15.00  from holding Moleculin Biotech or generate 5.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Moleculin Biotech  vs.  Mediwound

 Performance 
       Timeline  
Moleculin Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
Mediwound 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mediwound are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Mediwound is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Moleculin Biotech and Mediwound Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moleculin Biotech and Mediwound

The main advantage of trading using opposite Moleculin Biotech and Mediwound positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Mediwound can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mediwound will offset losses from the drop in Mediwound's long position.
The idea behind Moleculin Biotech and Mediwound pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA